Journal Article

DKFZ-2020-00333

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Serum levels of hsa-miR-16-5p, -29a-3p, -150-5p, -155-5p and -223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.

Casabonne, D. ; Benavente, Y. ; Seifert, J. ; Costas, L. ; Armesto, M. ; Arestin, M. ; Besson, C. ; Saberi Hosnijeh, F. ; Duell, E. J. ; Weiderpass, E. ; Masala, G. ; Kaaks, R.DKFZ* ; Canzian, F.DKFZ* ; Chirlaque, M.-D. ; Perduca, V. ; Mancini, F. R. ; Pala, V. ; Trichopoulou, A. ; Karakatsani, A. ; La Vecchia, C. ; Sánchez, M.-J. ; Tumino, R. ; Gunter, M. J. ; Amiano, P. ; Panico, S. ; Sacerdote, C. ; Schmidt, J. A. ; Boeing, H. ; Schulze, M. B. ; Barricarte, A. ; Riboli, E. ; Olsen, A. ; Tjønneland, A. ; Vermeulen, R. ; Nieters, A. ; Lawrie, C. H. ; de Sanjosé, S.

2020
Wiley-Liss Bognor Regis

This record in other databases:  

Please use a persistent id in citations: doi:10.1002/ijc.32894

Abstract: Serum levels of hsa-miR-16-5p, -29a-3p, -150-5p, -155-5p and -223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.

Note: 2020 Sep 1;147(5):1315-1324

---

Contributing Institute(s):

1. C020 Epidemiologie von Krebs (C020)
2. C055 Genomische Epidemiologie (C055)

Research Program(s):

1. 313 - Cancer risk factors and prevention (POF3-313) (POF3-313)

Appears in the scientific report 2020

---

Database coverage:
; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; Nationallizenz ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection

---